Clover Health stockholders elect directors, approve say-on-pay, ratify EY as auditor at 2024 annual meeting

CLOVER HEALTH INVESTMENTS, CORP. /DE

Elected Chelsea Clinton, Carladenise Armbrister Edwards, and Vivek Garipalli as Class III directors with over 937M votes each.
Non-binding advisory vote to approve 2023 named executive officer compensation passed with ~950.6M for vs ~11M against.
Ratified Ernst & Young LLP as independent auditor for 2024 with ~1.1B votes for, ~5.3M against.
Broker non-votes of ~145.2M on director election and say-on-pay proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.